Exciting news! Datexim featured in "Improving the Pap test with AI." Explore our CytoProcessor advancing AI algorithms for enhanced Pap test analysis. Link to the scientific article: 🔗https://t.co/pRucQ3XSgE
#DigitalCytology#Scientificarticle
Our R&D Team is recognized in "Computational Pathology" for exploring AI integration research, addressing significant clinical challenges in the medical domain. Link to the article: 🔗https://t.co/CpjcbIQek7 📷Computational Pathology: A Survey Review and The Way Forward
Our CytoProcessor® solution is featured in the scientific article "A Cytopathologist Eye Assistant for Cell Screening," recognizing its AI-powered impact in precise cell differentiation and classification.
Link to the article: https://t.co/WIv455fJ8G
#scientificarticle#datexim
Discover how digital pathology has revolutionized the field, allowing remote evaluation of slides, global collaboration, and advanced image analysis.
🔗:https://t.co/YLlUHV19qJ
#datexim#digitalcytology#ai#clinicalstudies#research
Discover how Artificial Intelligence is transforming pathology and the associated challenges mentioned in a recent article by Datexim. Explore the impact of AI on slide digitization quality.
🔗: Find out more: https://t.co/W5HSzncyay
#datexim#digitalcytology
Thrilled to see our CytoProcessor® featured in a research paper : https://t.co/l6QHTM27xp
Committed to making cervical cancer screening accessible, we aim to save thousands of lives with our AI-powered solution.
#cytology#academictwitter#research#clinicalstudies#datexim
Vom 22. bis 24. September nahm Datexim an der 12. Jahrestagung der AZÄD teil, die in Köln stattfand. Diese Messe Arnaud Renouf die Gelegenheit, CytoProcessor®, die durch Künstliche Intelligenz unterstützte Screening-Lösung, vorzustellen. 🧬
#pathology#digitalcytology#datexim
Even in the summer, Datexim continues to work on its digital solution and on the various stakeholders of the cervical cancer project. 🧬
The members of the different poles meet every week in order to move forward with a common goal.
#datexim#cervicalcancer#digitalcytology
Cytoprocessor, the first CE marked AI-based image analysis for cervical cancer. 🖥
We believe in helping the healthcare community save women’s lives thanks to our accurate, reliable, and reproducible automated assistance.🧬
#datexim#ai#digitalcytology#medtech#cervicalcancer
Cytoprocessor, the first CE marked AI-based image analysis for cervical cancer. 🖥
We believe in helping the healthcare community save women’s lives thanks to our accurate, reliable, and reproducible automated assistance.🧬
#datexim#ai#digitalcytology#medtech#cervicalcancer
Working at Datexim means having quality material at your disposal 🖥
With a common goal to fight against cervical cancer, to encourage screening and to promote a digital cytology solution,Datexim believes that it is essential to have a healthy and pleasant environment to work in.
Working at Datexim means having quality material at your disposal 🖥
With a common goal to fight against cervical cancer, to encourage screening and to promote a digital cytology solution,Datexim believes that it is essential to have a healthy and pleasant environment to work in.
Our many webinars are available in replay on our website.
All dealing with various topics around digital cytology, such as AI adoption, testimonials of routine use CytoProcessor™ digital cytology and artificial intelligence solution and many more.
👉https://t.co/SUgloQQnDr
𝐓𝐚𝐥𝐤 𝐚𝐧𝐝 𝐭𝐞𝐬𝐭 !
Screening can detect abnormalities in the cells of the cervix and treat them before they develop into cancer or diagnose cancers at an early stage and thus improve the chances of cure.
At Datexim, we promote Cervical Cancer Screening. 🖥